{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,10]],"date-time":"2026-06-10T16:31:33Z","timestamp":1781109093204,"version":"3.54.1"},"reference-count":68,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,4,22]],"date-time":"2026-04-22T00:00:00Z","timestamp":1776816000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2026,6,4]],"date-time":"2026-06-04T00:00:00Z","timestamp":1780531200000},"content-version":"vor","delay-in-days":43,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"funder":[{"name":"The Construction Fund of Key Medical Disciplines of Hangzhou - Rare Disease","award":["2025HZZD09"],"award-info":[{"award-number":["2025HZZD09"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Med"],"DOI":"10.1186\/s12916-026-04871-3","type":"journal-article","created":{"date-parts":[[2026,4,22]],"date-time":"2026-04-22T07:54:42Z","timestamp":1776844482000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":1,"title":["Predicting amyotrophic lateral sclerosis stage based on multi-parameter ultrasound: development and validation of an interpretable machine learning model"],"prefix":"10.1186","volume":"24","author":[{"given":"Tianhua","family":"Yang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ying","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nan","family":"Dong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Junling","family":"Ding","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xinyi","family":"Yan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jialei","family":"Luo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Peijun","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yuxuan","family":"Qiu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ting","family":"Lin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jiahui","family":"Tong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jiayi","family":"Mao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yunyi","family":"Dai","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Haojie","family":"Shentu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shizhen","family":"Tang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Li","family":"Sheng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Min","family":"Zhao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gaoyi","family":"Yang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,4,22]]},"reference":[{"key":"4871_CR1","first-page":"1","volume":"3","author":"O Hardiman","year":"2017","unstructured":"Hardiman O, Al-Chalabi A, Chio A, et al. Amyotrophic lateral sclerosis. Nat Rev Dis Primers. 2017;3:1\u201319.","journal-title":"Nat Rev Dis Primers"},{"key":"4871_CR2","doi-asserted-by":"publisher","first-page":"465","DOI":"10.1016\/S1474-4422(21)00414-2","volume":"21","author":"SA Goutman","year":"2022","unstructured":"Goutman SA, Hardiman O, Al-Chalabi A, et al. Emerging insights into the complex genetics and pathophysiology of amyotrophic lateral sclerosis. Lancet Neurol. 2022;21:465\u201379.","journal-title":"Lancet Neurol"},{"key":"4871_CR3","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-024-49954-y","volume":"15","author":"D Amaral","year":"2024","unstructured":"Amaral D, Soares DF, Gromicho M, et al. Temporal stratification of amyotrophic lateral sclerosis patients using disease progression patterns. Nat Commun. 2024;15:5717.","journal-title":"Nat Commun"},{"key":"4871_CR4","doi-asserted-by":"crossref","unstructured":"EFNS Task Force on Diagnosis and Management of Amyotrophic Lateral Sclerosis:, Andersen PM, Abrahams S, et al. EFNS guidelines on the clinical management of amyotrophic lateral sclerosis (MALS)--revised report of an EFNS task force. Eur J Neurol. 2012;19:360\u2013375.","DOI":"10.1111\/j.1468-1331.2011.03501.x"},{"key":"4871_CR5","doi-asserted-by":"publisher","first-page":"1258","DOI":"10.1136\/jnnp.74.9.1258","volume":"74","author":"BJ Traynor","year":"2003","unstructured":"Traynor BJ, Alexander M, Corr B, et al. Effect of a multidisciplinary amyotrophic lateral sclerosis (ALS) clinic on ALS survival: a population based study, 1996\u20132000. J Neurol Neurosurg Psychiatry. 2003;74:1258\u201361.","journal-title":"J Neurol Neurosurg Psychiatry"},{"issue":"619\u2013631","key":"4871_CR6","first-page":"xi","volume":"19","author":"AS Mayadev","year":"2008","unstructured":"Mayadev AS, Weiss MD, Distad BJ, et al. The amyotrophic lateral sclerosis center: a model of multidisciplinary management. Phys Med Rehabil Clin N Am. 2008;19(619\u2013631):xi.","journal-title":"Phys Med Rehabil Clin N Am"},{"key":"4871_CR7","doi-asserted-by":"publisher","first-page":"165","DOI":"10.1136\/jnnp-2020-323271","volume":"92","author":"A Al-Chalabi","year":"2021","unstructured":"Al-Chalabi A, Chi\u00f2 A, Merrill C, et al. Clinical staging in amyotrophic lateral sclerosis: analysis of Edaravone Study 19. J Neurol Neurosurg Psychiatry. 2021;92:165\u201371.","journal-title":"J Neurol Neurosurg Psychiatry"},{"key":"4871_CR8","doi-asserted-by":"publisher","first-page":"304","DOI":"10.1080\/21678421.2022.2154678","volume":"24","author":"P Gebrehiwet","year":"2023","unstructured":"Gebrehiwet P, Meng L, Rudnicki SA, et al. MiToS and King\u2019s staging as clinical outcome measures in ALS: a retrospective analysis of the FORTITUDE-ALS trial. Amyotroph Lateral Scler Frontotemporal Degener. 2023;24:304\u201310.","journal-title":"Amyotroph Lateral Scler Frontotemporal Degener"},{"key":"4871_CR9","doi-asserted-by":"publisher","first-page":"1180","DOI":"10.1136\/jnnp-2014-310176","volume":"86","author":"I Tramacere","year":"2015","unstructured":"Tramacere I, Dalla Bella E, Chi\u00f2 A, et al. The MITOS system predicts long-term survival in amyotrophic lateral sclerosis. J Neurol Neurosurg Psychiatry. 2015;86:1180\u20135.","journal-title":"J Neurol Neurosurg Psychiatry"},{"key":"4871_CR10","doi-asserted-by":"publisher","first-page":"45","DOI":"10.1136\/jnnp-2013-306865","volume":"86","author":"R Balendra","year":"2015","unstructured":"Balendra R, Jones A, Jivraj N, et al. Use of clinical staging in amyotrophic lateral sclerosis for phase 3 clinical trials. J Neurol Neurosurg Psychiatry. 2015;86:45\u20139.","journal-title":"J Neurol Neurosurg Psychiatry"},{"key":"4871_CR11","doi-asserted-by":"publisher","first-page":"4105","DOI":"10.1093\/brain\/awad129","volume":"146","author":"A Maranzano","year":"2023","unstructured":"Maranzano A, Verde F, Colombo E, et al. Regional spreading pattern is associated with clinical phenotype in amyotrophic lateral sclerosis. Brain. 2023;146:4105\u201316.","journal-title":"Brain"},{"key":"4871_CR12","doi-asserted-by":"publisher","first-page":"805","DOI":"10.1212\/WNL.0b013e3181b6bbbd","volume":"73","author":"JM Ravits","year":"2009","unstructured":"Ravits JM, La Spada AR. ALS motor phenotype heterogeneity, focality, and spread: deconstructing motor neuron degeneration. Neurology. 2009;73:805\u201311.","journal-title":"Neurology"},{"key":"4871_CR13","doi-asserted-by":"publisher","first-page":"13","DOI":"10.1016\/S0022-510X(99)00210-5","volume":"169","author":"JM Cedarbaum","year":"1999","unstructured":"Cedarbaum JM, Stambler N, Malta E, et al. The ALSFRS-R: a revised ALS functional rating scale that incorporates assessments of respiratory function. J Neurol Sci. 1999;169:13\u201321.","journal-title":"J Neurol Sci"},{"key":"4871_CR14","doi-asserted-by":"publisher","first-page":"397","DOI":"10.3109\/21678421.2013.764568","volume":"14","author":"E Beghi","year":"2013","unstructured":"Beghi E, Pupillo E, Bonito V, et al. Randomized double-blind placebo-controlled trial of acetyl-L-carnitine for ALS. Amyotroph Lateral Scler Frontotemporal Degener. 2013;14:397\u2013405.","journal-title":"Amyotroph Lateral Scler Frontotemporal Degener"},{"key":"4871_CR15","doi-asserted-by":"publisher","first-page":"1059","DOI":"10.1016\/S1474-4422(13)70221-7","volume":"12","author":"ME Cudkowicz","year":"2013","unstructured":"Cudkowicz ME, van den Berg LH, Shefner JM, et al. Dexpramipexole versus placebo for patients with amyotrophic lateral sclerosis (EMPOWER): a randomised, double-blind, phase 3 trial. Lancet Neurol. 2013;12:1059\u201367.","journal-title":"Lancet Neurol"},{"key":"4871_CR16","doi-asserted-by":"publisher","DOI":"10.1186\/s12955-022-01919-9","volume":"20","author":"SL Hartmaier","year":"2022","unstructured":"Hartmaier SL, Rhodes T, Cook SF, et al. Qualitative measures that assess functional disability and quality of life in ALS. Health Qual Life Outcomes. 2022;20:12.","journal-title":"Health Qual Life Outcomes"},{"key":"4871_CR17","doi-asserted-by":"publisher","first-page":"1340","DOI":"10.1136\/jnnp-2012-304701","volume":"84","author":"F Franchignoni","year":"2013","unstructured":"Franchignoni F, Mora G, Giordano A, et al. Evidence of multidimensionality in the ALSFRS-R scale: a critical appraisal on its measurement properties using Rasch analysis. J Neurol Neurosurg Psychiatry. 2013;84:1340\u20135.","journal-title":"J Neurol Neurosurg Psychiatry"},{"key":"4871_CR18","doi-asserted-by":"publisher","first-page":"3276","DOI":"10.1021\/acs.jproteome.0c00216","volume":"19","author":"MS Bereman","year":"2020","unstructured":"Bereman MS, Kirkwood KI, Sabaretnam T, et al. Metabolite profiling reveals predictive biomarkers and the absence of \u03b2-methyl amino-l-alanine in plasma from individuals diagnosed with amyotrophic lateral sclerosis. J Proteome Res. 2020;19:3276\u201385.","journal-title":"J Proteome Res"},{"key":"4871_CR19","doi-asserted-by":"publisher","DOI":"10.1038\/s42003-025-08578-8","volume":"8","author":"W Xu","year":"2025","unstructured":"Xu W, Guo Z, Guan Y, et al. Machine learning-based proteomics profiling of ALS identifies downregulation of RPS29 that maintains protein homeostasis and STMN2 level. Commun Biol. 2025;8:1177.","journal-title":"Commun Biol"},{"key":"4871_CR20","doi-asserted-by":"publisher","first-page":"3440","DOI":"10.1038\/s41591-025-03890-6","volume":"31","author":"R Chia","year":"2025","unstructured":"Chia R, Moaddel R, Kwan JY, et al. A plasma proteomics-based candidate biomarker panel predictive of amyotrophic lateral sclerosis. Nat Med. 2025;31:3440\u201350.","journal-title":"Nat Med"},{"key":"4871_CR21","doi-asserted-by":"publisher","DOI":"10.1186\/s40478-025-02109-6","volume":"13","author":"L-S Scholl","year":"2025","unstructured":"Scholl L-S, Demleitner AF, Riedel J, et al. Identification and validation of a tear fluid-derived protein biomarker signature in patients with amyotrophic lateral sclerosis. Acta Neuropathol Commun. 2025;13:187.","journal-title":"Acta Neuropathol Commun"},{"key":"4871_CR22","doi-asserted-by":"publisher","first-page":"e59","DOI":"10.1212\/WNL.0000000000009559","volume":"95","author":"M Benatar","year":"2020","unstructured":"Benatar M, Zhang L, Wang L, et al. Validation of serum neurofilaments as prognostic and potential pharmacodynamic biomarkers for ALS. Neurology. 2020;95:e59\u201369.","journal-title":"Neurology"},{"key":"4871_CR23","doi-asserted-by":"publisher","first-page":"1040","DOI":"10.1002\/ana.27054","volume":"96","author":"S Witzel","year":"2024","unstructured":"Witzel S, Huss A, Nagel G, et al. Population-Based Evidence for the Use of Serum Neurofilaments as Individual Diagnostic and Prognostic Biomarkers in Amyotrophic Lateral Sclerosis. Ann Neurol. 2024;96:1040\u201357.","journal-title":"Ann Neurol"},{"key":"4871_CR24","doi-asserted-by":"publisher","first-page":"525","DOI":"10.1001\/jamaneurol.2016.5398","volume":"74","author":"A Gaiani","year":"2017","unstructured":"Gaiani A, Martinelli I, Bello L, et al. Diagnostic and Prognostic Biomarkers in Amyotrophic Lateral Sclerosis: Neurofilament Light Chain Levels in Definite Subtypes of Disease. JAMA Neurol. 2017;74:525\u201332.","journal-title":"JAMA Neurol"},{"key":"4871_CR25","doi-asserted-by":"publisher","DOI":"10.3389\/fmolb.2025.1608853","volume":"12","author":"F Anjum","year":"2025","unstructured":"Anjum F, Bakhuraysah M, Alsharif A, et al. Emerging biomarkers in amyotrophic lateral sclerosis: from pathogenesis to clinical applications. Front Mol Biosci. 2025;12:1608853.","journal-title":"Front Mol Biosci"},{"key":"4871_CR26","doi-asserted-by":"publisher","first-page":"5235","DOI":"10.1007\/s10787-025-01901-z","volume":"33","author":"P Goleij","year":"2025","unstructured":"Goleij P, Amini A, Sanaye PM, et al. The IL-12 family cytokines in neurodegenerative diseases: dual roles in neurotoxicity and neuroprotection. Inflammopharmacology. 2025;33:5235\u201356.","journal-title":"Inflammopharmacology"},{"key":"4871_CR27","doi-asserted-by":"publisher","first-page":"585","DOI":"10.1056\/NEJM199403033300901","volume":"330","author":"G Bensimon","year":"1994","unstructured":"Bensimon G, Lacomblez L, Meininger V. A controlled trial of riluzole in amyotrophic lateral sclerosis. ALS\/Riluzole Study Group. N Engl J Med. 1994;330:585\u201391.","journal-title":"N Engl J Med"},{"key":"4871_CR28","doi-asserted-by":"publisher","DOI":"10.1038\/s41598-017-05430-w","volume":"7","author":"R Jia","year":"2017","unstructured":"Jia R, Shepheard S, Jin J, et al. Urinary extracellular domain of neurotrophin receptor p75 as a biomarker for amyotrophic lateral sclerosis in a Chinese cohort. Sci Rep. 2017;7:5127.","journal-title":"Sci Rep"},{"key":"4871_CR29","doi-asserted-by":"publisher","first-page":"1598","DOI":"10.1093\/brain\/awac077","volume":"145","author":"JS Katzeff","year":"2022","unstructured":"Katzeff JS, Bright F, Phan K, et al. Biomarker discovery and development for frontotemporal dementia and amyotrophic lateral sclerosis. Brain. 2022;145:1598\u2013609.","journal-title":"Brain"},{"key":"4871_CR30","doi-asserted-by":"publisher","DOI":"10.1016\/j.nicl.2020.102327","volume":"27","author":"A Weerasekera","year":"2020","unstructured":"Weerasekera A, Crabb\u00e9 M, Tom\u00e9 SO, et al. Non-invasive characterization of amyotrophic lateral sclerosis in a hTDP-43A315T mouse model: a PET-MR study. Neuroimage Clin. 2020;27:102327.","journal-title":"Neuroimage Clin"},{"key":"4871_CR31","doi-asserted-by":"publisher","DOI":"10.1016\/j.nicl.2024.103633","volume":"43","author":"H-P M\u00fcller","year":"2024","unstructured":"M\u00fcller H-P, Abrahao A, Beaulieu C, et al. Temporal and spatial progression of microstructural cerebral degeneration in ALS: A multicentre longitudinal diffusion tensor imaging study. Neuroimage Clin. 2024;43:103633.","journal-title":"Neuroimage Clin"},{"key":"4871_CR32","doi-asserted-by":"publisher","first-page":"784","DOI":"10.1007\/s00259-022-05987-3","volume":"50","author":"A Canosa","year":"2023","unstructured":"Canosa A, Martino A, Manera U, et al. Role of brain 2-[18F]fluoro-2-deoxy-D-glucose-positron-emission tomography as survival predictor in amyotrophic lateral sclerosis. Eur J Nucl Med Mol Imaging. 2023;50:784\u201391.","journal-title":"Eur J Nucl Med Mol Imaging"},{"key":"4871_CR33","doi-asserted-by":"publisher","first-page":"114","DOI":"10.1002\/mus.26487","volume":"60","author":"LD Hobson-Webb","year":"2019","unstructured":"Hobson-Webb LD, Simmons Z. Ultrasound in the diagnosis and monitoring of amyotrophic lateral sclerosis: a review. Muscle Nerve. 2019;60:114\u201323.","journal-title":"Muscle Nerve"},{"key":"4871_CR34","doi-asserted-by":"publisher","first-page":"253","DOI":"10.1002\/mus.27669","volume":"66","author":"J Wijntjes","year":"2022","unstructured":"Wijntjes J, van der Hoeven J, Saris CGJ, et al. Visual versus quantitative analysis of muscle ultrasound in neuromuscular disease. Muscle Nerve. 2022;66:253\u201361.","journal-title":"Muscle Nerve"},{"key":"4871_CR35","doi-asserted-by":"publisher","DOI":"10.1159\/000546425","author":"J Wu","year":"2025","unstructured":"Wu J, Song H, Arkin M, et al. Characteristics of neuromuscular ultrasound in patients with amyotrophic lateral sclerosis. Neurodegener Dis. 2025. https:\/\/doi.org\/10.1159\/000546425.","journal-title":"Neurodegener Dis"},{"key":"4871_CR36","doi-asserted-by":"publisher","first-page":"1532","DOI":"10.1212\/WNL.0b013e318233b36a","volume":"77","author":"S Misawa","year":"2011","unstructured":"Misawa S, Noto Y, Shibuya K, et al. Ultrasonographic detection of fasciculations markedly increases diagnostic sensitivity of ALS. Neurology. 2011;77:1532\u20137.","journal-title":"Neurology"},{"key":"4871_CR37","doi-asserted-by":"publisher","first-page":"354","DOI":"10.1016\/j.ultrasmedbio.2007.08.013","volume":"34","author":"IMP Arts","year":"2008","unstructured":"Arts IMP, van Rooij FG, Overeem S, et al. Quantitative muscle ultrasonography in amyotrophic lateral sclerosis. Ultrasound Med Biol. 2008;34:354\u201361.","journal-title":"Ultrasound Med Biol"},{"key":"4871_CR38","doi-asserted-by":"publisher","first-page":"442","DOI":"10.3389\/fneur.2018.00442","volume":"9","author":"X Chen","year":"2018","unstructured":"Chen X, Wei Q-Q, Chen Y, et al. Clinical staging of amyotrophic lateral sclerosis in Chinese patients. Front Neurol. 2018;9:442.","journal-title":"Front Neurol"},{"key":"4871_CR39","doi-asserted-by":"publisher","DOI":"10.1186\/s12913-021-06191-z","volume":"21","author":"K Tobin","year":"2021","unstructured":"Tobin K, Maguire S, Corr B, et al. Discrete choice experiment for eliciting preference for health services for patients with ALS and their informal caregivers. BMC Health Serv Res. 2021;21:213.","journal-title":"BMC Health Serv Res"},{"key":"4871_CR40","doi-asserted-by":"publisher","DOI":"10.1016\/j.jns.2023.120764","volume":"452","author":"K Stenson","year":"2023","unstructured":"Stenson K, O\u2019Callaghan L, Mellor J, et al. Healthcare resource utilization at different stages of amyotrophic lateral sclerosis: results from a real-world survey. J Neurol Sci. 2023;452:120764.","journal-title":"J Neurol Sci"},{"key":"4871_CR41","doi-asserted-by":"publisher","first-page":"56","DOI":"10.1038\/s42256-019-0138-9","volume":"2","author":"SM Lundberg","year":"2020","unstructured":"Lundberg SM, Erion G, Chen H, et al. From local explanations to global understanding with explainable AI for trees. Nat Mach Intell. 2020;2:56\u201367.","journal-title":"Nat Mach Intell"},{"key":"4871_CR42","doi-asserted-by":"publisher","first-page":"478","DOI":"10.1080\/21678421.2021.1903506","volume":"22","author":"J Luna","year":"2021","unstructured":"Luna J, Couratier P, Lahmadi S, et al. Comparison of the ability of the King\u2019s and MiToS staging systems to predict disease progression and survival in amyotrophic lateral sclerosis. Amyotroph Lateral Scler Frontotemporal Degener. 2021;22:478\u201385.","journal-title":"Amyotroph Lateral Scler Frontotemporal Degener"},{"key":"4871_CR43","doi-asserted-by":"publisher","first-page":"165","DOI":"10.1080\/21678421.2022.2150555","volume":"24","author":"A Genge","year":"2023","unstructured":"Genge A, Chio A. The future of ALS diagnosis and staging: where do we go from here? Amyotroph Lateral Scler Frontotemporal Degener. 2023;24:165\u201374.","journal-title":"Amyotroph Lateral Scler Frontotemporal Degener"},{"key":"4871_CR44","doi-asserted-by":"publisher","first-page":"884","DOI":"10.3390\/diagnostics15070884","volume":"15","author":"M Iglesias","year":"2025","unstructured":"Iglesias M, Casc\u00f3n JA, Maim\u00f3 A, et al. Evaluation of Diaphragmatic Ultrasound in Respiratory Functional Assessment in Patients with ALS. Diagnostics (Basel). 2025;15:884.","journal-title":"Diagnostics (Basel)"},{"key":"4871_CR45","doi-asserted-by":"publisher","first-page":"892","DOI":"10.1016\/j.clinph.2015.03.024","volume":"127","author":"S Pinto","year":"2016","unstructured":"Pinto S, Alves P, Pimentel B, et al. Ultrasound for assessment of diaphragm in ALS. Clin Neurophysiol. 2016;127:892\u20137.","journal-title":"Clin Neurophysiol"},{"key":"4871_CR46","doi-asserted-by":"publisher","first-page":"932","DOI":"10.1111\/resp.12759","volume":"21","author":"R Fantini","year":"2016","unstructured":"Fantini R, Mandrioli J, Zona S, et al. Ultrasound assessment of diaphragmatic function in patients with amyotrophic lateral sclerosis. Respirology. 2016;21:932\u20138.","journal-title":"Respirology"},{"issue":"Suppl","key":"4871_CR47","doi-asserted-by":"publisher","first-page":"35","DOI":"10.1016\/0022-510X(95)00057-9","volume":"129","author":"T Evangelista","year":"1995","unstructured":"Evangelista T, Carvalho M, Pinto A, et al. Phrenic nerve conduction in amyotrophic lateral sclerosis. J Neurol Sci. 1995;129(Suppl):35\u20137.","journal-title":"J Neurol Sci"},{"key":"4871_CR48","doi-asserted-by":"publisher","first-page":"213","DOI":"10.3109\/21678421.2015.1112406","volume":"17","author":"JAL Jenkins","year":"2016","unstructured":"Jenkins JAL, Sakamuri S, Katz JS, et al. Phrenic nerve conduction studies as a biomarker of respiratory insufficiency in amyotrophic lateral sclerosis. Amyotroph Lateral Scler Frontotemporal Degener. 2016;17:213\u201320.","journal-title":"Amyotroph Lateral Scler Frontotemporal Degener"},{"key":"4871_CR49","doi-asserted-by":"publisher","first-page":"143","DOI":"10.3389\/fneur.2019.00143","volume":"10","author":"M de Carvalho","year":"2019","unstructured":"de Carvalho M, Swash M, Pinto S. Diaphragmatic neurophysiology and respiratory markers in ALS. Front Neurol. 2019;10:143.","journal-title":"Front Neurol"},{"key":"4871_CR50","doi-asserted-by":"publisher","DOI":"10.3390\/jcm14196702","volume":"14","author":"A Maciel","year":"2025","unstructured":"Maciel A, Resqueti VR, Costa L, et al. The impact of respiratory function on functionality and mortality in ALS patients. J Clin Med. 2025;14:6702.","journal-title":"J Clin Med"},{"key":"4871_CR51","doi-asserted-by":"publisher","first-page":"345","DOI":"10.1007\/s00455-010-9315-z","volume":"26","author":"WG Pearson","year":"2011","unstructured":"Pearson WG, Langmore SE, Zumwalt AC. Evaluating the structural properties of suprahyoid muscles and their potential for moving the hyoid. Dysphagia. 2011;26:345\u201351.","journal-title":"Dysphagia"},{"key":"4871_CR52","doi-asserted-by":"publisher","DOI":"10.1016\/j.clinph.2025.2111367","volume":"179","author":"K Yanagawa","year":"2025","unstructured":"Yanagawa K, Ike M, Aoyama A, et al. Tongue shear wave elastography for bulbar dysfunction in amyotrophic lateral sclerosis. Clin Neurophysiol. 2025;179:2111367.","journal-title":"Clin Neurophysiol"},{"key":"4871_CR53","doi-asserted-by":"publisher","DOI":"10.1016\/j.nicl.2020.102233","volume":"26","author":"N Hensiek","year":"2020","unstructured":"Hensiek N, Schreiber F, Wimmer T, et al. Sonographic and 3T-MRI-based evaluation of the tongue in ALS. Neuroimage Clin. 2020;26:102233.","journal-title":"Neuroimage Clin"},{"key":"4871_CR54","doi-asserted-by":"publisher","first-page":"284","DOI":"10.1038\/s41598-020-78747-8","volume":"11","author":"AB Martins-Bach","year":"2021","unstructured":"Martins-Bach AB, Bachasson D, Araujo ECA, et al. Non-invasive assessment of skeletal muscle fibrosis in mice using nuclear magnetic resonance imaging and ultrasound shear wave elastography. Sci Rep. 2021;11:284.","journal-title":"Sci Rep"},{"key":"4871_CR55","doi-asserted-by":"publisher","first-page":"465","DOI":"10.1148\/radiol.2015150908","volume":"278","author":"AB Rosskopf","year":"2016","unstructured":"Rosskopf AB, Ehrmann C, Buck FM, et al. Quantitative Shear-Wave US Elastography of the Supraspinatus Muscle: Reliability of the Method and Relation to Tendon Integrity and Muscle Quality. Radiology. 2016;278:465\u201374.","journal-title":"Radiology"},{"key":"4871_CR56","doi-asserted-by":"publisher","DOI":"10.1038\/s41598-024-74669-x","volume":"14","author":"S Kawata","year":"2024","unstructured":"Kawata S, Seki S, Nishiura A, et al. Preservation of masseter muscle until the end stage in the SOD1G93A mouse model for ALS. Sci Rep. 2024;14:24279.","journal-title":"Sci Rep"},{"key":"4871_CR57","doi-asserted-by":"publisher","DOI":"10.1016\/j.archger.2023.105038","volume":"113","author":"C-S Lin","year":"2023","unstructured":"Lin C-S, Liu L-K, Chen L-K, et al. Association between masseter muscle volume, nutritional status, and cognitive status in older people. Arch Gerontol Geriatr. 2023;113:105038.","journal-title":"Arch Gerontol Geriatr"},{"key":"4871_CR58","doi-asserted-by":"publisher","DOI":"10.1080\/07853890.2025.2578733","volume":"57","author":"T Yang","year":"2025","unstructured":"Yang T, Wang Y, Yan X, et al. Association between Onodera\u2019s prognostic nutritional Index and ultrasound-measured muscle thickness in amyotrophic lateral sclerosis: a retrospective cross-sectional study. Ann Med. 2025;57:2578733.","journal-title":"Ann Med"},{"key":"4871_CR59","doi-asserted-by":"publisher","first-page":"1480","DOI":"10.1016\/j.clinph.2020.04.003","volume":"131","author":"A Abraham","year":"2020","unstructured":"Abraham A, Fainmesser Y, Lovblom LE, et al. Superiority of sonographic evaluation of contracted versus relaxed muscle thickness in motor neuron diseases. Clin Neurophysiol. 2020;131:1480\u20136.","journal-title":"Clin Neurophysiol"},{"key":"4871_CR60","doi-asserted-by":"publisher","first-page":"814","DOI":"10.1002\/mus.21779","volume":"42","author":"CD Lee","year":"2010","unstructured":"Lee CD, Song Y, Peltier AC, et al. Muscle ultrasound quantifies the rate of reduction of muscle thickness in amyotrophic lateral sclerosis. Muscle Nerve. 2010;42:814\u20139.","journal-title":"Muscle Nerve"},{"key":"4871_CR61","doi-asserted-by":"publisher","first-page":"687","DOI":"10.1002\/mus.26693","volume":"60","author":"A Abraham","year":"2019","unstructured":"Abraham A, Drory VE, Fainmesser Y, et al. Muscle thickness measured by ultrasound is reduced in neuromuscular disorders and correlates with clinical and electrophysiological findings. Muscle Nerve. 2019;60:687\u201392.","journal-title":"Muscle Nerve"},{"key":"4871_CR62","doi-asserted-by":"publisher","first-page":"453","DOI":"10.1136\/jnnp.34.4.453","volume":"34","author":"AJ McComas","year":"1971","unstructured":"McComas AJ, Sica RE, Campbell MJ, et al. Functional compensation in partially denervated muscles. J Neurol Neurosurg Psychiatry. 1971;34:453\u201360.","journal-title":"J Neurol Neurosurg Psychiatry"},{"key":"4871_CR63","doi-asserted-by":"publisher","first-page":"725","DOI":"10.1016\/S1474-4422(07)70193-X","volume":"6","author":"V Dietz","year":"2007","unstructured":"Dietz V, Sinkjaer T. Spastic movement disorder: impaired reflex function and altered muscle mechanics. Lancet Neurol. 2007;6:725\u201333.","journal-title":"Lancet Neurol"},{"key":"4871_CR64","doi-asserted-by":"publisher","first-page":"46","DOI":"10.1016\/S0022-510X(96)00037-8","volume":"143","author":"CD Reimers","year":"1996","unstructured":"Reimers CD, Schlotter B, Eicke BM, et al. Calf enlargement in neuromuscular diseases: a quantitative ultrasound study in 350 patients and review of the literature. J Neurol Sci. 1996;143:46\u201356.","journal-title":"J Neurol Sci"},{"key":"4871_CR65","doi-asserted-by":"publisher","first-page":"8490","DOI":"10.3390\/s21248490","volume":"21","author":"A Romano","year":"2021","unstructured":"Romano A, Staber D, Grimm A, et al. Limitations of Muscle Ultrasound Shear Wave Elastography for Clinical Routine-Positioning and Muscle Selection. Sensors (Basel). 2021;21:8490.","journal-title":"Sensors (Basel)"},{"key":"4871_CR66","doi-asserted-by":"publisher","first-page":"392","DOI":"10.11152\/mu-1113","volume":"19","author":"AM Alfuraih","year":"2017","unstructured":"Alfuraih AM, O\u2019Connor P, Tan AL, et al. An investigation into the variability between different shear wave elastography systems in muscle. Med Ultrason. 2017;19:392\u2013400.","journal-title":"Med Ultrason"},{"key":"4871_CR67","doi-asserted-by":"publisher","DOI":"10.3389\/fneur.2021.749736","volume":"12","author":"M Paoletti","year":"2021","unstructured":"Paoletti M, Diamanti L, Muzic SI, et al. Longitudinal Quantitative MRI Evaluation of Muscle Involvement in Amyotrophic Lateral Sclerosis. Front Neurol. 2021;12:749736.","journal-title":"Front Neurol"},{"key":"4871_CR68","doi-asserted-by":"publisher","first-page":"908","DOI":"10.1136\/jnnp-2024-335571","volume":"96","author":"U Klickovic","year":"2025","unstructured":"Klickovic U, Zampedri L, Zafeiropoulos N, et al. Muscle MRI quantifies disease progression in amyotrophic lateral sclerosis. J Neurol Neurosurg Psychiatry. 2025;96:908\u201311.","journal-title":"J Neurol Neurosurg Psychiatry"}],"container-title":["BMC Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12916-026-04871-3","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12916-026-04871-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12916-026-04871-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,6,4]],"date-time":"2026-06-04T02:01:51Z","timestamp":1780538511000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1186\/s12916-026-04871-3"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,4,22]]},"references-count":68,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["4871"],"URL":"https:\/\/doi.org\/10.1186\/s12916-026-04871-3","relation":{},"ISSN":["1741-7015"],"issn-type":[{"value":"1741-7015","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,4,22]]},"assertion":[{"value":"27 November 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"13 April 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"22 April 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"This study was approved by the Institutional Review Board of Affiliated Hangzhou First People's Hospital, School of Medicine, Westlake University. As a retrospective study, informed consent was waived (Protocol No.: 2025ZN292-1). All procedures involving human participants were conducted in accordance with the ethical standards of the institutional and\/or national research committee, as well as the 1964 Declaration of Helsinki and its later amendments or comparable ethical standards.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"342"}}